TOP TIERMARKET NEWSWIRE
News & sentiment

IMMUNITYBIO INC (IBRX) — News & AI sentiment

IMMUNITYBIO INC (IBRX) news roundup. 3 stories in the past week, 37 over 30 days. Average 30-day sentiment is 59.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $1.1M — net selling of $1.1M. US House Periodic Transaction Reports (90-day window): 2 purchases (~$16K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 56.3/100
30d stories
37
avg sentiment 59.3/100
Insider net (90d)
$1.1M
0 buys · 2 sells
Congress (90d)
2
2 buys · 0 sells

IBRX news in the last 24 hours, 7 days, 30 days and 90 days

How much IBRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIBRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days356.3/100IBRX headlines →
Last 30 days3759.3/100IBRX headlines →
Last 90 days5958.7/100IBRX headlines →

Latest stories on IBRX

1d ago
2d ago
7d ago
Oct 21
Oct 21
Oct 21
ImmunityBio falls -5.7%
The Fly38 · neutralgeneral
Oct 19
Oct 19
Oct 19
Oct 16
Oct 16
Oct 16
Oct 15
Oct 15
Oct 15
Oct 15
ImmunityBio, Inc. (IBRX) files 8-K
SEC 8-K50 · neutralgeneral
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Open IBRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →